HIV / AIDS in the News

Trodelvy misses again in lung cancer, but Gilead and Merck have an HIV success to soften the blow - Endpoints News

 

Gilead and MSD’s once-weekly HIV pill meets primary endpoints in Phase III trials - Clinical Trials Arena

 

Revealing the assembly of HIV's integration complex - Drug Discovery News

 

Sustaining HIV Impact in MENA: Community Coalitions and Regional Coordination and Leadership - Policy Brief - ReliefWeb

 

Merck, Gilead serve ‘sweet and sour’ spread after HIV win, cancer stumble - BioSpace

 

South Africa launches HIV prevention drug lenacapavir in the country - Shoreline Media Group

 

Wisp Collaborates with Mount Sinai to Expand Access to PrEP and HIV Prevention Across New York State - Business Wire

 

Cantor Fitzgerald reiterates Gilead stock rating on HIV trial data - Investing.com

 

Lenacapavir: the HIV Breakthrough Proving Why NIH Funding Matters - Think Global Health

 

Highly effective prevention drug arrives in South Africa, which has high HIV burden - livingstonenterprise.net

 

June 9 - National HIV Testing Day Events Scheduled for June 27 in Chatham and Glynn Counties - Savannah Business Journal

 

Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment - BioSpace

 

Highly effective prevention drug arrives in South Africa, which has world's highest HIV burden - Medical Xpress

 

Highly effective prevention drug arrives in South Africa, which has world's highest HIV burden - AP News

 

Will HIV Win and Lung Cancer Loss in Trials Recast Merck’s (MRK) Risk Reward Narrative? - Yahoo Finance

 

'We're not seeing a rebound': New data shows HIV services not recovering - Devex

 

Highly effective prevention drug arrives in South Africa, which has world's highest HIV burden - Toronto Star

 

Highly effective prevention drug arrives in South Africa, which has world's highest HIV burden - AP News

 

Highly effective prevention drug arrives in South Africa, which has world's highest HIV burden - The Killeen Daily Herald

 

Highly effective prevention drug arrives in South Africa, which has world's highest HIV burden - The Independent

 

Highly effective prevention drug arrives in South Africa, which has world's highest HIV burden - Yahoo

 

45 years after first AIDS report, HIV cases are rising again in NYC - Spectrum News NY1

 

Gilead-MSD once-weekly oral HIV regimen meets Phase III endpoints - European Pharmaceutical Review

 

New Long Acting Oral HIV Regimen Meets Primary Endpoints In Phase 3 Trials - NDTV

 

aidsmap: Worse HIV control at diagnosis doesn’t mean worse lymphoma outcomes - European AIDS Treatment Group

 

The Conversation: HIV enters the brain and doesn’t leave – paradoxically, drugs intended to reduce brain inflammation increase virus levels - European AIDS Treatment Group

 

South Africa Rolls Out Game-Changing HIV Shot Amid Funding Shortfalls - nextbillion.net

 

Gilead's lung cancer bid for Trodelvy hits wall, but HIV studies deliver better news - FirstWord Pharma

 

[Press release] Gilead and Merck announce positive topline results from two Phase 3 studies evaluating islatravir/lenacapavir, an oral once-weekly HIV treatment - European AIDS Treatment Group

 

AIDS Memorial Quilt on display as UCSD’s Owen Clinic holds vigil for those lost to HIV - Times of San Diego